| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |